Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: I'd consider selling MMP if USPTO re-validates

Obviously, the price would be the key factor, and I'm not sure what the appropriate price would be, but if PTSC could get $200M to $250M now for it, vs. $800M to $1B over 10 years, it could allow RG to pursue a myriad of M&A options now and move things as far as the exchange we trade on, etc



654 companies engaged...400 that are greater than 1Bil in size. 20 industry segments. Meeting with 96 percent more companies since last SHM

http://agoracom.com/ir/patriot/messa...



I humbly suggest that once revalidated there will be a rapid increase in the number of licensees, with PTSC's revenue share far exceeding the suggested selling price during the following 24 months.





Be well

Share
New Message
Please login to post a reply